Accenture (ACN) Stock Forecast & Price Target

$353.57 -8.50 (-2.35%)

(As of 11/15/2024 ET)

Accenture - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
9

Buy
13

Based on 22 Wall Street analysts who have issued ratings for Accenture in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 9 have given a hold rating, and 13 have given a buy rating for ACN.

Consensus Price Target

$368.23
4.15% Upside

According to the 22 analysts' twelve-month price targets for Accenture, the average price target is $368.23. The highest price target for ACN is $445.00, while the lowest price target for ACN is $275.00. The average price target represents a forecasted upside of 4.15% from the current price of $353.57.

ACN Analyst Ratings Over Time

Type	Current Forecast 11/17/23 to 11/16/24	1 Month Ago 10/18/23 to 10/17/24	3 Months Ago 8/19/23 to 8/18/24	1 Year Ago 11/17/22 to 11/17/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)	10 Buy rating(s)
Hold	9 Hold rating(s)	8 Hold rating(s)	10 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$368.23	$371.18	$351.82	$337.26
Forecasted Upside	4.15% Upside	-1.10% Downside	7.62% Upside	2.87% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Tech funds are hemorrhaging cash: Sell this stock now (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

ACN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Accenture Stock vs. The Competition

Type	Accenture	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.59	2.67	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	4.15% Upside	551.81% Upside	9.87% Upside
News Sentiment Rating	Positive News See Recent ACN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/30/2024	BNP Paribas 3 of 5 stars	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$375.00	+4.90%
9/30/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$350.00 ➝ $415.00	+17.77%
9/30/2024	TD Cowen 4 of 5 stars	B. Bergin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$321.00 ➝ $400.00	+14.38%
9/27/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$400.00 ➝ $415.00	+18.03%
9/27/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$380.00 ➝ $395.00	+11.89%
9/27/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$377.00 ➝ $389.00	+9.76%
Tech funds are hemorrhaging cash: Sell this stock now (Ad) Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here.
9/27/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$380.00 ➝ $390.00	+10.05%
9/27/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$350.00 ➝ $370.00	+3.99%
9/27/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$365.00 ➝ $388.00	+9.05%
9/27/2024	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$350.00 ➝ $360.00	+1.18%
9/26/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Ramnani Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$329.00 ➝ $395.00	+11.79%
9/24/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$376.00 ➝ $370.00	+9.46%
9/20/2024	Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral	$329.00	-1.86%
9/18/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$352.00 ➝ $365.00	+8.62%
9/17/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$350.00 ➝ $405.00	+19.35%
6/26/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$382.00 ➝ $300.00	-2.35%
6/24/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Schneider Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$335.00	+8.42%
6/12/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$400.00 ➝ $350.00	+19.58%
6/12/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$395.00 ➝ $340.00	+15.55%
6/5/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$340.00 ➝ $275.00	-4.86%
5/15/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$409.00 ➝ $295.00	-3.86%
3/19/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$410.00 ➝ $445.00	+19.41%
7/7/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$314.00 ➝ $373.00	+21.10%
4/5/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
3/24/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight	$289.00 ➝ $294.00	+8.22%
3/20/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Nolan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
12/19/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$295.00 ➝ $300.00	+13.43%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:36 PM ET.

Should I Buy Accenture Stock? ACN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, November 2, 2024. Please send any questions or comments about these Accenture pros and cons to contact@marketbeat.com.

Accenture
Bull Case

Here are some ways that investors could benefit from investing in Accenture:

Accenture's stock price has been steadily increasing, reaching $365.11 on the latest trading day, indicating positive market sentiment.
Recent analyst ratings have been favorable, with multiple firms raising their price targets and giving buy ratings, suggesting strong growth potential.
Insider trading activity shows confidence in the company, with insiders selling shares at higher prices, indicating belief in future performance.
Accenture's market capitalization of $228.81 billion reflects its position as a large and stable company in the information technology services sector.
The company's PE ratio of 33.43 and P/E/G ratio of 3.69 indicate reasonable valuation and potential for future earnings growth.

Accenture
Bear Case

Investors should be bearish about investing in Accenture for these reasons:

Despite positive analyst ratings, there is always a level of uncertainty in the market that could impact stock performance.
Accenture's beta of 1.25 indicates slightly higher volatility compared to the market average, which may not suit risk-averse investors.
The company's 52-week high of $387.51 suggests potential resistance at higher price levels, limiting short-term upside.
Investors should consider potential market corrections or economic downturns that could affect Accenture's stock price in the future.
While the company has shown growth, competition in the IT services sector is intense, which could impact Accenture's market share and profitability.

ACN Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Accenture is $368.23, with a high forecast of $445.00 and a low forecast of $275.00.
: 22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accenture in the last twelve months. There are currently 9 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ACN shares.
: According to analysts, Accenture's stock has a predicted upside of 4.15% based on their 12-month stock forecasts.
: Over the previous 90 days, Accenture's stock had 2 upgrades and 1 downgrade by analysts.
: Accenture has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, BNP Paribas, Citigroup, Guggenheim, JPMorgan Chase & Co., Mizuho, Piper Sandler, Piper Sandler Companies, Robert W. Baird, Royal Bank of Canada, Susquehanna, TD Cowen, and UBS Group in the past 90 days.
: Analysts like Accenture less than other "computer and technology" companies. The consensus rating score for Accenture is 2.59 while the average consensus rating score for "computer and technology" companies is 2.67. Learn more on how ACN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Tech funds are hemorrhaging cash: Sell this stock now (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

This page (NYSE:ACN) was last updated on 11/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accenture (ACN) Stock Forecast & Price Target